Autolus Therapeutics (AUTL)
Autolus Therapeutics Statistics
Share Statistics
Autolus Therapeutics has 266.14M shares outstanding. The number of shares has increased by 0.03% in one year.
| 266.14M |
| 0.03% |
| 0% |
| 63.26% |
| n/a |
| 22 |
| n/a |
Short Selling Information
The latest short interest is 10.59M, so 3.98% of the outstanding shares have been sold short.
| 10.59M |
| 3.98% |
| 5.24% |
| 4.1 |
Valuation Ratios
The PE ratio is -2.72 and the forward PE ratio is -3.02. Autolus Therapeutics's PEG ratio is 0.1.
| -2.72 |
| -3.02 |
| 59.25 |
| 0.9 |
| 1.4 |
| -2.49 |
| 0.1 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Autolus Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 10.88, with a Debt / Equity ratio of 0.12.
| 10.88 |
| 10.81 |
| 0.12 |
| -0.29 |
| -0.22 |
| -25.98 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $15,641.42 |
| $-341,054.1 |
| 647 |
| 0.01 |
| 2.75 |
Taxes
| 1.53M |
| -0.7% |
Stock Price Statistics
The stock price has increased by -47.2% in the last 52 weeks. The beta is 1.74, so Autolus Therapeutics's price volatility has been higher than the market average.
| 1.74 |
| -47.2% |
| 1.47 |
| 2.61 |
| 80.27 |
| 2,044,195 |
Income Statement
In the last 12 months, Autolus Therapeutics had revenue of 10.12M and earned -220.66M in profits. Earnings per share was -0.86.
| 10.12M |
| -1.27M |
| -241.43M |
| -220.66M |
| -182.42M |
| -209.84M |
| -0.86 |
Balance Sheet
The company has 227.38M in cash and 52.63M in debt, giving a net cash position of 174.75M.
| 227.38M |
| 52.63M |
| 174.75M |
| -1.1B |
| 746.34M |
| 549.16M |
Cash Flow
In the last 12 months, operating cash flow was -206.27M and capital expenditures -34.82M, giving a free cash flow of -241.09M.
| -206.27M |
| -34.82M |
| -241.09M |
| -0.94 |
Margins
Gross margin is -12.52%, with operating and profit margins of -2385.63% and -2180.45%.
| -12.52% |
| -2385.63% |
| -2165.36% |
| -2180.45% |
| -1802.61% |
| -2385.63% |
| -2382.31% |
Dividends & Yields
AUTL does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for AUTL is $10, which is 342.5% higher than the current price. The consensus rating is "Buy".
| $10 |
| 342.5% |
| Buy |
| 5 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -1.67 |
| 1 |